References
- Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323–30.
- Yoo GH, Xu JJ, Brennan JA, et al. Infrequent inacti-vation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994; 54: 4603–6.
- Field JK, Spandidos DA, Steil PM, Vaughan ED, Evan GI, Moore JP. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 1989; 4: 1463–8.
- Lucas JM, Mountain RE, Gramza AW, Schuller DE, Wilkie NM, Lang JC. Expression of cyclin D1 in squamous cell carcinomas of the head and neck. Int .1 Oncol 1994; 5: 469–72.
- Field JK, Spandidos DA, Donckerwolcke RA. Overex-pression of p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet 1992; 339: 502–3.
- Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704–7.
- Tam SW, Shay JW, Pagano M. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p 161n". Cancer Res 1994; 54: 5816–20.
- Lilischkis R, Sarcevic B, Kennedy C, Warlters A, Sutherland RL. Cancer-associated mis-sense and dele-tion mutations impair pl6Ink4 CDK inhibitory activity. Int .1 Cancer 1996; 66: 249–54.
- Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436–40.
- Mori T, Kiura K, Aoki T, Nishihira T, Mori S, Naka-mura Y. Frequent somatic mutation of the MTS1/ CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994; 54: 3396–7.
- Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753–6.
- Otsuki T, Clark HM, Wellmann A, Jaffe ES, Raffeld M. Involvement of CDKN2 (p16Ink4A/MTS1) and p 15Ink4B/MTS2 in human leukemias and lymphomas. Cancer Res 1995; 55: 1436–40.
- Shapiro GI, Edwards CD, Kobzik L, et al. Reciprocal Rb inactivation and p16'4 expression in primary lung cancers and cell lines. Cancer Res 1995; 55: 505–9.
- Zhang S-Y, Klein-Szanto A, Sauter ER, et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 1994; 54: 5050–3.
- Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56: 3630–3.
- Olshan AF, Weissler MC, Pei H, et al. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997; 14: 811–8.
- Lang JC, Tobin EJ, Knobloch TJ, et al. Frequent mutation of p16 in squamous cell carcinoma of the head and neck. Laryngoscope 1998; 108: 923–8.
- Pinyol M, Cobo F, Bea S, et al. p16'4a gene inactiva-tion by deletions, mutations and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91: 2977–84.
- Fizzotti M, Cimino G, Pisegna S, et al. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 1995; 85: 2685–90.
- Dong Y, Walsh MD, McGuckin MA, et al. Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16INK4A in ovarian cancer is associated with progression and unfavourable progno-sis. Int .1 Cancer 1997; 74: 57–63.
- Taga S, Osaki T, Ohgami A, et al. Prognostic value of the immunohistochemical detection of p16INK4A ex-pression of nonsmall cell lung carcinoma. Cancer 1997; 80: 389–95.
- Lydiatt WM, Davidson BJ, Schantz S, Caruana S, Chaganti RSK. 9p21 deletion correlates with recur-rence in head and neck cancer. Head Neck 1998; 20: 113–8.
- Reed JA, Loganzo F Jr, Shea CR, et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions corre-lates with invasive stage of tumor progression. Cancer Res 1995; 55: 2713–8.
- Gramza AW, Lucas JM, Mountain RE, Schuller DE, Lang JC. Efficient method for preparing normal and tumor tissue for RNA extraction. BioTechniques 1995; 18: 228–9.
- Okamoto A, Demetrick DJ, Spillare EA, et al. p16INK4 mutations and altered expression in human tumors and cell lines. Cold Spring Harbor Symp Quant Biol 1994; 59: 49–57.